These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34087864)

  • 1. Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients.
    Tang J; Lin J; Zhang E; Zhong M; Luo Y; Fu Y; Yang Y
    Medicine (Baltimore); 2021 Jun; 100(22):e26131. PubMed ID: 34087864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of PCT, IL-6, and CRP in the early diagnosis and evaluation of COVID-19.
    Zhou YZ; Teng XB; Han MF; Shi JF; Li CX; Zhang XH; Hou DY; Yang LL
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):1097-1100. PubMed ID: 33577066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
    Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
    Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
    Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
    Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin is a predictor of disseminated intravascular coagulation in patients with fatal COVID-19.
    Asoğlu R; Tibilli H; Afşin A; Türkmen S; Barman HA; Asoğlu E
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11953-11959. PubMed ID: 33275269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
    Srinivasan A; Kumar N; Scott JX
    Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
    Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
    Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
    Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
    Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions.
    Song J; Park DW; Moon S; Cho HJ; Park JH; Seok H; Choi WS
    BMC Infect Dis; 2019 Nov; 19(1):968. PubMed ID: 31718563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.
    Tang ML; Li YQ; Chen X; Lin H; Jiang ZC; Gu DL; Chen X; Tang CX; Xie ZQ
    Med Sci Monit; 2021 Jan; 27():e929783. PubMed ID: 33388738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
    Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
    Front Immunol; 2021; 12():646095. PubMed ID: 33815405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
    Lugito NPH
    Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of C-reactive protein, procalcitonin, interleukin-6 and neutrophil / lymphocyte ratio as a laboratory biomarker in COVID-19.
    Al-Juboori RSF; Al-Bayaa YJ
    Egypt J Immunol; 2024 Apr; 31(2):93-101. PubMed ID: 38615266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia.
    Milenkovic M; Hadzibegovic A; Kovac M; Jovanovic B; Stanisavljevic J; Djikic M; Sijan D; Ladjevic N; Palibrk I; Djukanovic M; Velickovic J; Ratkovic S; Brajkovic M; Popadic V; Klasnja S; Toskovic B; Zdravkovic D; Crnokrak B; Markovic O; Bjekic-Macut J; Aleksic A; Petricevic S; Memon L; Milojevic A; Zdravkovic M
    Oxid Med Cell Longev; 2022; 2022():8997709. PubMed ID: 35237386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.